Inhibitory effect of oleanolic acid on 12-O-tetradecanoylphorbol-13-acetate-induced gene expression in mouse skin

T Oguro1, J Liu, C D Klaassen

  • 1Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

Insights

Oleanolic acid (OA) significantly inhibits tumor promotion by TPA in mouse skin. It reduces TPA-induced gene expression of ornithine decarboxylase (ODC) and metallothionein (MT), suggesting OA is a general inhibitor of TPA-stimulated genes.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Oleanolic acid (OA) is known to inhibit skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA).
  • The precise molecular mechanisms underlying OA's inhibitory effects require further investigation.

Purpose of the Study:

  • To investigate the impact of OA on TPA-induced gene expression, specifically focusing on ornithine decarboxylase (ODC) and other related genes.
  • To elucidate the potential role of OA as an inhibitor of TPA-mediated signal transduction pathways.

Main Methods:

  • CD-1 mice were treated with OA and/or TPA.
  • Epidermal ODC activity and mRNA levels were measured.
  • Gene expression of metallothionein (MT) and c-fos was analyzed via mRNA levels.

Main Results:

  • OA pretreatment significantly reduced TPA-induced ODC activity and mRNA levels by approximately 50%.
  • OA also inhibited TPA-induced metallothionein (MT) mRNA expression by 50%.
  • OA administration post-TPA treatment inhibited ODC and MT gene expression, indicating it doesn't compete for the TPA receptor.

Conclusions:

  • Oleanolic acid inhibits TPA-induced ODC expression primarily at the transcriptional level.
  • OA appears to interfere with TPA-induced signal transduction pathways, suppressing target gene expression.
  • OA demonstrates potential as a general inhibitor against TPA-stimulated gene expression in mouse skin.

Related Concept Videos